To embed, copy and paste the code into your website or blog:
In part one, Wiley Health Care Practice partners Dot Powell-Woodson and Rachel Alexander break down the background, substance, and procedural issues of the two Final Drug Pricing Rules released on November 30, 2020: the Most-Favored Nations (MFN) Rule and the Rebate Rule.
Embed
To embed, copy and paste the code into your website or blog:
In part two, Wiley Health Care Practice partners Dot Powell-Woodson and Rachel Alexander continue their discussion of the Most-Favored Nations (MFN) Rule and the Rebate Rule and look at the potential impacts of these Final Rules on managed care companies.
Embed